09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
In what appears to be a growing trend, state and federal regulators are launching investigations int...
Read More >
As every new year begins, the idea of law firm merger grabs the attention of more than a few law fir...
Read More >
Background - On June 12, 2019, the Dubai International Financial Center (“DIFC”) in Dubai, UAE a...
Read More >
As the number of confirmed novel coronavirus cases (COVID-19) continues to grow, we recommend health...
Read More >
Seyfarth Synopsis: On Wednesday, July 24, 2019, approximately one week before San Antonio’s paid s...
Read More >
An enforceable restraint of trade can be a key business asset, giving an employer time to recover wh...
Read More >